Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Manufacture Small Molecules, COVID-19

A Year of Challenge and Opportunity

This article was published in our sister publication, The Small Molecule Manufacturer, which celebrates the field of small molecule drug development and manufacturing with interviews and articles focusing on success stories, equipment, and new processing techniques. Read more about The Small Molecule Manufacturer here.

What has been Dr. Reddy’s main priority during the pandemic?

The past few months have been very intense. The COVID-19 pandemic is affecting lives, so we must find ways to support as many people as possible. 

One of our first steps was to ensure that our workforce and their families were in good health. We have taken a host of measures in this regard so that we can continue to provide much-needed medicines to patients through this period of uncertainty.  For our colleagues who work at our manufacturing sites, laboratories, and distribution centers, we have put in place additional layers of health and safety procedures to provide them with a safe working environment. These include significantly enhancing capacity of our buses for social distancing, temperature checks at all entry and exit points, providing PPEs to employees and contractors, disinfecting machines to spray outer garments and shoe soles as well as social distancing measures. In addition, some plants were used to make disinfectants and hand sanitizer. We are also closely following and complying with the advice from our local governments and health authorities, and have issued guidance for remote working for all our colleagues who can do so.

How else is the company addressing the crisis?

The pandemic has raised questions on the reliability of global supply chains and companies are now trying to ensure its resilience and reliability. A strong supply chain network with reliable partners is key to addressing the problem. Fortunately, we had already started to implement initiatives to help mitigate risks well before the COVID-19 outbreak began. In recent years, we have formed strategic sourcing and logistic partnerships, reassessed our capacity management systems for our manufacturing units, and included the backward integration of key starting materials into our production processes. We are also continuing to mitigate geographical risks by leveraging our manufacturing set up across three continents, for both our APIs and for our formulations.

Do you think COVID-19 will affect how the industry operates in the long term?

In our industry, most companies quickly moved to working remotely through digitized processes and video conferencing. I think we all saw how COVID-19 accelerated the adoption of digitalization. I hope we can keep this agility and speed for continued improvement in efficiency and work practices. 

Enjoy our FREE content!

Log in or register to gain full unlimited access to all content on the The Medicine Maker site. It’s FREE!

Login

Or register now - it’s free!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

When you click “Register” we will email you a link, which you must click to verify the email address above and activate your account. If you do not receive this email, please contact us at [email protected].

About the Author

Maryam Mahdi

Associate Editor

After finishing my degree, I envisioned a career in science communications. However, life took an unexpected turn and I ended up teaching abroad. Though the experience was amazing and I learned a great deal from it, I jumped at the opportunity to work for Texere. I'm excited to see where this new journey takes me!

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register